Escient Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Escient Pharmaceuticals Ownership

Who owns Escient Pharmaceuticals?

Escient Pharmaceuticals is owned by Incyte. It was acquired on April 23, 2024.

Escient Pharmaceuticals Business Overview

Where is Escient Pharmaceuticals headquartered?

Escient Pharmaceuticals is headquartered in San Diego, California.

What sector is Escient Pharmaceuticals in?

Escient Pharmaceuticals is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 197 acquisitions of life science companies in 2024, including 18 acquisitions by private equity firms, and 179 by strategics.

Escient Pharmaceuticals

Escient Pharmaceuticals

10578 Science Center Drive # 250,
San Diego, California 92121
United States,
(858) 617-8220
www.escientpharma.com

Escient Pharmaceuticals is a clinical-stage company that develops novel therapeutics to address various neurosensory-inflammatory disorders. The company’s pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for treating various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Escient Pharmaceuticals is based in San Diego, California.


 Subscribe to unlock this and 208,151
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.